Tekturna

Type: Product
Name: Tekturna
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

EMA: Don't Combine ARBs, ACE-Is, and Direct Renin Inhibitors

LONDON, UK — No two drug classes that act separately on the renin-angiotensin system (RAS) should be used in combination, the European Medicines Agency (EMA) warned today [1] . According to the European drug regulator, angiotensin-receptor blockers (ARBs), ... [Published American Journal of Public Health - Apr 11 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Tekturna Should Not Be Used In Combination With Certain Other Blood Pressure Drugs Due To Side Effects Hyperkalemia And Kidney Problems, Says Health Canada

In Addition, Such Combined Use In Patients With Kidney Disease Or Diabetes Increases Risks Of Having A Stroke As Well As Fainting And Falling (Posted by Tom Lamb at DrugInjuryWatch.com ) In February 2014 Health Canada issued new safety information ... [Published Drug Injury Watch - Mar 25 2014]

Quotes

"Where such combination (dual blockade) is considered absolutely necessary, it must be carried out under specialist supervision with close monitoring of kidney function, fluid and salt balance, and blood pressure" an EMA press release states...
We have written in more detail about the increased risks of serious side effects associated with Tekturna in this 2012 article: "Tekturna And Other Aliskiren Related Blood Pressure Medications Can Cause Renal Failure, Kidney Complications, And Strokes"

More Content

All (2) | News (1) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
EMA: Don't Combine ARBs, ACE-Is, and Direct Ren... [Published American Journal of Public Health - Apr 11 2014]
Tekturna Should Not Be Used In Combination With... [Published Drug Injury Watch - Mar 25 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Tekturna Should Not Be Used In Combination With... [Published Drug Injury Watch - Mar 25 2014]
In Addition, Such Combined Use In Patients With Kidney Disease Or Diabetes Increases Risks Of Having A Stroke As Well As Fainting And Falling (Posted by Tom Lamb at DrugInjuryWatch.com ) In February 2014 Health Canada issued new safety information ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.